Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRAX Praxis Precision Medicines, Inc.

Post-Mkt 03-26 19:20:17 EDT

302.69

-9.23

-2.96%

盘后302.69

+0.000.00%

16:32 EDT

High315.00	Low300.91	Vol419.90K
Open311.92	D1 Closing311.92	Amplitude4.52%
Mkt Cap8.43B	Tradable Cap7.80B	Total Shares27.85M
T/O129.23M	T/O Rate1.63%	Tradable Shares25.78M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRAX","market":"US","secType":"STK","nameCN":"Praxis Precision Medicines, Inc.","latestPrice":302.69,"timestamp":1774555200000,"preClose":311.92,"halted":0,"volume":419898,"hourTrading":{"tag":"盘后","latestPrice":302.69,"preClose":302.69,"latestTime":"16:32 EDT","volume":4384,"amount":1326992.96,"timestamp":1774557129542,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.029590920748910034,"floatShares":25778700,"shares":27850833,"eps":-13.475777,"marketStatus":"Post-Mkt","change":-9.23,"latestTime":"03-26 19:20:17 EDT","open":311.92,"high":315,"low":300.91,"amount":129225696.39306,"amplitude":0.045172,"askPrice":302.38,"askSize":1,"bidPrice":300,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-13.475777,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774569600000},"marketStatusCode":4,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":311.92,"preHourTrading":{"tag":"盘前","latestPrice":311.91,"preClose":311.92,"latestTime":"08:53 EDT","volume":33,"amount":10212.810300000001,"timestamp":1774529592956,"change":-0.01,"changeRate":-0.000032,"amplitude":0.012247},"postHourTrading":{"tag":"盘后","latestPrice":302.69,"preClose":302.69,"latestTime":"16:32 EDT","volume":4384,"amount":1326992.96,"timestamp":1774557129542,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.727905,"impliedVol":0.7592,"impliedVolPercentile":0.2789},"requestUrl":"/m/hq/s/PRAX/tweets","defaultTab":"tweets","newsList":[{"id":"2618919535","title":"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Biohaven Ltd. (BHVN) and Siemens Healthineers AG (OtherSEMHF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618919535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618919535?lang=en_us&edition=fundamental","pubTime":"2026-03-11 15:20","pubTimestamp":1773213645,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX – Research Report),...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-biohaven-ltd-bhvn-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-biohaven-ltd-bhvn-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0109394709.USD","BK4585","PRAX","BHVN","IE00BFTCPJ56.SGD","LU1093756168.USD","IE00B2B36J28.USD","LU0320765992.SGD","LU0128526141.USD","AG","LU0029874061.USD","BK4137","IE00BJT1NW94.SGD","XLV","IE0002141913.USD","IE0009355771.USD","LU1093756325.SGD","XBI","IE00B4R5TH58.HKD","BK4581","IE00BJJMRZ35.SGD","BK4588","LU0889565916.HKD","BK4210","LABU","BK4139"],"gpt_icon":0},{"id":"2617664685","title":"Praxis Precision Medicines Grants 2,931 RSUs Under 2024 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2617664685","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617664685?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:01","pubTimestamp":1772658092,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines Inc. granted restricted stock unit awards covering a total of 2,931 shares of common stock to 14 new non-executive employees under its 2024 Inducement Plan. The awards vest in four equal annual installments, contingent on continued employment on each vesting date.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL6FQp5S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4112","SG9999014005.SGD","IE00B3QW5Z07.USD","LU0109394709.USD","BK4585","LU2210149790.SGD","PRAX","LU2095319765.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE00B2B36J28.USD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BJT1NW94.SGD","NDAQ","SG9999014021.USD","SG9999014039.USD","IE0002141913.USD","IE00BKPKM429.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0314104364.USD","BK4588","LU0889565916.HKD","BK4139","SG9999014013.SGD"],"gpt_icon":0},{"id":"2617456950","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617456950","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617456950?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:01","pubTimestamp":1772658060,"startTime":"0","endTime":"0","summary":"Investor Contact:. 857-702-9452. Media Contact:. Dan Ferry. LifeSci Advisors. 617-430-7576","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/04/3249717/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","BK4561","BK4135","ASO","BK4200","CNS","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","PRAX","LU0109394709.USD","BK4139","IE00BJT1NW94.SGD","IE0009355771.USD","LU0320765992.SGD","LU0889565916.HKD","IE0002141913.USD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2613716211","title":"Praxis Precision Med Initiated at Outperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2613716211","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613716211?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:25","pubTimestamp":1771935900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2026 07:25 ET (12:25 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4139","PRAX"],"gpt_icon":0},{"id":"2613730509","title":"Praxis Precision initiated with an Outperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2613730509","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613730509?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:16","pubTimestamp":1771881393,"startTime":"0","endTime":"0","summary":"Wolfe Research initiated coverage of Praxis Precision (PRAX) with an Outperform rating and $500 price target The firm launched coverage of the neur...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-an-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-an-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0889565916.HKD","PRAX","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2613963277","title":"Praxis Precision Medicines Maps Aggressive Path to Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2613963277","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613963277?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:25","pubTimestamp":1771806338,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, Inc. (($PRAX)) has held its Q4 earnings call. Read on for the main highlights of the call. Praxis Precision Medicines’ ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/praxis-precision-medicines-maps-aggressive-path-to-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/praxis-precision-medicines-maps-aggressive-path-to-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","PRAX","BK4139","IE00B2B36J28.USD","IE0002141913.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0320765992.SGD","IE0009355771.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2613296498","title":"Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2613296498","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613296498?lang=en_us&edition=fundamental","pubTime":"2026-02-21 01:10","pubTimestamp":1771607439,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50756039/praxis-precision-medicine-analysts-raise-their-forecasts-after-q4-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","PRAX","IE0002141913.USD","BK4139","LU0889565916.HKD","IE0009355771.USD","LU0320765992.SGD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"1105640608","title":"Stock Track | Praxis Precision Medicines Soars 5.12% Intraday on Multiple Analyst Price Target Increases","url":"https://stock-news.laohu8.com/highlight/detail?id=1105640608","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105640608?lang=en_us&edition=fundamental","pubTime":"2026-02-20 23:52","pubTimestamp":1771602759,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, Inc. (PRAX) experienced a significant intraday surge, with its stock price soaring 5.12%. The movement occurred during the regular trading session, reflecting heightened...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRAX"],"gpt_icon":0},{"id":"2612298921","title":"Praxis Precision price target raised to $700 from $500 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2612298921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612298921?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:51","pubTimestamp":1771599060,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on Praxis Precision (PRAX) to $700 from $500 and keeps a Buy rating on the shares. The company’s Q4 update wa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-700-from-500-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-700-from-500-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","PRAX","IE00B2B36J28.USD","LU0889565916.HKD","BK4139","IE0009355771.USD","IE00BJT1NW94.SGD","LU0109394709.USD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2612382298","title":"Truist Boosts Price Target on Praxis Precision Medicines to $700 From $500, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2612382298","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612382298?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:49","pubTimestamp":1771598971,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) has an average rating of buy and mean price target of $607, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRAX"],"gpt_icon":0},{"id":"1143889427","title":"Stock Track | Praxis Precision Medicines Plummets 5.19% Intraday Despite Analyst Price Target Hikes as Wedbush Maintains Underperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1143889427","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143889427?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:39","pubTimestamp":1771598361,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines Inc. (PRAX) saw its stock price plummet by 5.19% during intraday trading on Friday, a sharp decline that occurred despite a flurry of positive analyst actions on the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRAX"],"gpt_icon":0},{"id":"2612730260","title":"JonesTrading Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612730260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612730260?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:35","pubTimestamp":1771598151,"startTime":"0","endTime":"0","summary":"In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Praxis Precision Medicines, with a price target of $441.00. W...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jonestrading-reaffirms-their-buy-rating-on-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jonestrading-reaffirms-their-buy-rating-on-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRAX"],"gpt_icon":0},{"id":"2612262049","title":"Praxis Precision Med Is Maintained at Underperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2612262049","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612262049?lang=en_us&edition=fundamental","pubTime":"2026-02-20 21:35","pubTimestamp":1771594500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 20, 2026 08:35 ET (13:35 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","PRAX","LU0109394709.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2612694522","title":"Praxis Precision price target raised to $305 from $282 at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2612694522","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612694522?lang=en_us&edition=fundamental","pubTime":"2026-02-20 19:32","pubTimestamp":1771587140,"startTime":"0","endTime":"0","summary":"Wells Fargo raised the firm’s price target on Praxis Precision (PRAX) to $305 from $282 and keeps an Equal Weight rating on the shares. The firm re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-305-from-282-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-305-from-282-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","LU0980610538.SGD","LU1894683264.USD","LU1267930490.SGD","LU0267386448.USD","LU0787776722.HKD","LU0310799852.SGD","LU0256863811.USD","LU0742534661.SGD","LU1814569148.SGD","LU0971096721.USD","BK4585","LU0130517989.USD","IE0002141913.USD","IE00B19Z3B42.SGD","LU1894683348.USD","LU2361044865.SGD","IE00B19Z3581.USD","LU0070302665.USD","LU0175139822.USD","LU1267930227.SGD","LU0149725797.USD","BK4139","LU0106831901.USD","LU0942090050.USD","LU0162691827.USD","LU0251131958.USD","LU0320765992.SGD","LU0208291251.USD","IE0002270589.USD","IE00B7SZLL34.SGD","LU0128525929.USD","LU0320765489.SGD","BK4501","LU0128525689.USD","IE00B2B36J28.USD","LU0072461881.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU0130102774.USD","LU1668664300.SGD","BK4207","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0868494617.USD","LU0868494708.USD","PRAX","LU1791807156.HKD","LU2236285917.USD","LU0640476718.USD"],"gpt_icon":0},{"id":"2612837252","title":"U.S. RESEARCH ROUNDUP-Dropbox, Etsy, Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2612837252","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612837252?lang=en_us&edition=fundamental","pubTime":"2026-02-20 15:08","pubTimestamp":1771571293,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Dropbox, Etsy, ZscalerFeb 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Dropbox, Etsy and Zsc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nL4N3ZG0E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","LU0175139822.USD","LU1989772923.USD","LYV","LU2125154935.USD","NP","UAL","BK4093","DBX","THRY","GH","W","CF","HQY","LU0320765646.SGD","LU1066051498.USD","ETSY","LU2125910500.SGD","LU2265009873.SGD","OHI","EBAY","PTCT","LU0511384066.AUD","SFM","AKAM","MRK","EPAM","DOCS","IRTC","CRL","DE","LMND","VEEV","OXY","CARG","PHR","BK4225","LMNX","ONTO","PWR","VC","TAP","CHH","BK4007","ROK","LU1201861249.SGD","BK4121","FIVN","BK4539","PRAX"],"gpt_icon":0},{"id":"2612287680","title":"Praxis Precision Medicines: NDA Progress, Robust Pipeline, and Strong Cash Runway Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2612287680","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612287680?lang=en_us&edition=fundamental","pubTime":"2026-02-20 03:15","pubTimestamp":1771528542,"startTime":"0","endTime":"0","summary":"Analyst Ritu Baral of TD Cowen maintained a Buy rating on Praxis Precision Medicines, retaining the price target of $554.00. Ritu Baral has given h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/praxis-precision-medicines-nda-progress-robust-pipeline-and-strong-cash-runway-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/praxis-precision-medicines-nda-progress-robust-pipeline-and-strong-cash-runway-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","PRAX"],"gpt_icon":0},{"id":"1195414131","title":"Stock Track | Praxis Precision Medicines Plummets 5.92% Intraday After Q4 Earnings Miss and Widening Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=1195414131","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195414131?lang=en_us&edition=fundamental","pubTime":"2026-02-19 22:35","pubTimestamp":1771511737,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines Inc. (PRAX) saw its shares plummet 5.92% during intraday trading on Thursday, as investors reacted negatively to the company's latest financial results.The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRAX"],"gpt_icon":0},{"id":"2612036400","title":"Praxis Precision Medicines Publishes Corporate Presentation on CNS Pipeline and Commercial Launch Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2612036400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612036400?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:33","pubTimestamp":1771508030,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines Inc. released a corporate presentation highlighting its late-stage CNS pipeline and key clinical and regulatory milestones. The company discussed ulixacaltamide for essential tremor, supported by two positive Phase 3 Essential3 studies and an NDA submission, as well as relutrigine for SCN2A/SCN8A developmental and epileptic encephalopathies , including Breakthrough Therapy Designation and an NDA submission. The presentation also covered elsunersen, an intrathecal antisense oligonucleotide for SCN2A gain-of-function DEE, and vormatrigine for focal and generalized epilepsy, including ongoing POWER studies and positioning within its broader epilepsy development program. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and sho","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDLbdVXMT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","PRAX","LU0889565916.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4139","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0109394709.USD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2612407649","title":"Earnings Flash (PRAX) Praxis Precision Medicines Posts Q4 Loss $3.50 a Share, vs. FactSet Est of $2.88 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2612407649","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612407649?lang=en_us&edition=fundamental","pubTime":"2026-02-19 20:43","pubTimestamp":1771505017,"startTime":"0","endTime":"0","summary":"Earnings Flash (PRAX) Praxis Precision Medicines Posts Q4 Loss $3.50 a Share, vs. FactSet Est of $2.88 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRAX"],"gpt_icon":0},{"id":"2612076374","title":"Praxis Precision posts bigger Q4 loss as R&D costs grow","url":"https://stock-news.laohu8.com/highlight/detail?id=2612076374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612076374?lang=en_us&edition=fundamental","pubTime":"2026-02-19 20:40","pubTimestamp":1771504834,"startTime":"0","endTime":"0","summary":"Praxis Precision posts bigger Q4 loss as R&D costs growOverviewCNS biopharmaceutical firm reported wider Q4 net loss of $88.9 mln, with increased R&D expensesPraxis submitted NDAs for ulixacaltamide a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nL1N3ZF0JG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","PRAX","IE0002141913.USD","BK4139","LU0889565916.HKD","IE0009355771.USD","LU0320765992.SGD","IE00B2B36J28.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.praxismedicines.com","stockEarnings":[{"period":"1week","weight":0.0801},{"period":"1month","weight":-0.0892},{"period":"3month","weight":0.1352},{"period":"6month","weight":4.9481},{"period":"1year","weight":7.6983},{"period":"ytd","weight":0.0583}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase IIb clinical trial for the treatment of essential tremor, as well as in Phase II clinical trial to treat Parkinson's disease; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.298328},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.166549},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.1653},{"month":4,"riseRate":0.2,"avgChangeRate":-0.018417},{"month":5,"riseRate":0.4,"avgChangeRate":-0.124101},{"month":6,"riseRate":0.4,"avgChangeRate":-0.094382},{"month":7,"riseRate":0.6,"avgChangeRate":0.167978},{"month":8,"riseRate":0.4,"avgChangeRate":0.080633},{"month":9,"riseRate":0.6,"avgChangeRate":0.013557},{"month":10,"riseRate":0.6,"avgChangeRate":0.512334},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073478},{"month":12,"riseRate":0.833333,"avgChangeRate":0.206625}],"exchange":"NASDAQ","name":"Praxis Precision Medicines, Inc.","nameEN":"Praxis Precision Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Praxis Precision Medicines, Inc.,PRAX,Praxis Precision Medicines, Inc.股票,Praxis Precision Medicines, Inc.股票老虎,Praxis Precision Medicines, Inc.股票老虎国际,Praxis Precision Medicines, Inc.行情,Praxis Precision Medicines, Inc.股票行情,Praxis Precision Medicines, Inc.股价,Praxis Precision Medicines, Inc.股市,Praxis Precision Medicines, Inc.股票价格,Praxis Precision Medicines, Inc.股票交易,Praxis Precision Medicines, Inc.股票购买,Praxis Precision Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Praxis Precision Medicines, Inc.(PRAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Praxis Precision Medicines, Inc.(PRAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}